JPRN-UMIN000013262尚未招募1 期
Phase II clinical trials of WT1 vaccine for post hematopoietic stem cell transplant patients - Phase II clinical trials of WT1 vaccine for post hematopoietic stem cell transplant patients
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 20years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)active infectious diseases 2)Severe Complications, including Heart failure, Renal faiure, Hapatic failure, ileus, uncontrolable DM, and so on 3)Other severe problems unsuitable for this study
研究者
相似试验
已完成
2 期
Phase II clinical trials of WT1 vaccine for post hematopoietic stem cell transplant patientsAcute leukemiaJPRN-UMIN000011780Osaka University45
已完成
1 期
Phase I/II clinical trial of WT1 peptide vaccine therapy for lung, breast, pancreas, stomach, and colorectal cancerung, breast, pancreas, stomach, and colorectal cancerJPRN-UMIN000011029Shinshu University50
已完成
不适用
Phase I/II clinical trial of WT1 peptide vaccine for the children with malignanciesJPRN-UMIN000002990Osaka Medical Center and Research Institute for Maternal and Child Health20
已完成
不适用
Phase II clinical trial of immunotherapy with WT1 peptide vaccination for pediatric hematological malignancies after allogeneic stem cell transplantation.Acute lymphoid or myeloid leukemia, acute unclassified leukemia, malignant lymphomaJPRN-UMIN000005319Osaka University22
已完成
1 期
Phase I clinical trial of WT1 peptide-based vaccine for the HLA-A*0201 positive patients with malignant tumors.Malignant solid tumors, Malignant lymphoma, Multiple Myeloma, Acute leukemiaJPRN-UMIN000000933Department of Cancer immunotherapy, Osaka University Medical School10